230 related articles for article (PubMed ID: 8781371)
1. Monitoring exposure to atomic bomb radiation by somatic mutation.
Akiyama M; Kyoizumi S; Kusunoki Y; Hirai Y; Tanabe K; Cologne JB
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):493-6. PubMed ID: 8781371
[TBL] [Abstract][Full Text] [Related]
2. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
[TBL] [Abstract][Full Text] [Related]
3. Individual variation of somatic gene mutability in relation to cancer susceptibility: prospective study on erythrocyte glycophorin a gene mutations of atomic bomb survivors.
Kyoizumi S; Kusunoki Y; Hayashi T; Hakoda M; Cologne JB; Nakachi K
Cancer Res; 2005 Jun; 65(12):5462-9. PubMed ID: 15958596
[TBL] [Abstract][Full Text] [Related]
4. Radiation-dose response of glycophorin A somatic mutation in erythrocytes associated with gene polymorphisms of p53 binding protein 1.
Yoshida K; Kusunoki Y; Cologne JB; Kyoizumi S; Maki M; Nakachi K; Hayashi T
Mutat Res; 2013 Jul; 755(1):49-54. PubMed ID: 23680719
[TBL] [Abstract][Full Text] [Related]
5. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
[TBL] [Abstract][Full Text] [Related]
7. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer.
Land CE
JAMA; 1995 Aug; 274(5):402-7. PubMed ID: 7616636
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
[TBL] [Abstract][Full Text] [Related]
9. Studies on chromosome aberrations and HPRT mutations in lymphocytes and GPA mutation in erythrocytes of atomic bomb survivors.
Akiyama M; Kyoizumi S; Hirai Y; Hakoda M; Nakamura N; Awa AA
Prog Clin Biol Res; 1990; 340C():69-80. PubMed ID: 2381941
[No Abstract] [Full Text] [Related]
10. High incidence of meningioma among Hiroshima atomic bomb survivors.
Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
[TBL] [Abstract][Full Text] [Related]
11. Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: a comparative study of assay methods.
Langlois RG; Akiyama M; Kusunoki Y; DuPont BR; Moore DH; Bigbee WL; Grant SG; Jensen RH
Radiat Res; 1993 Oct; 136(1):111-7. PubMed ID: 8210326
[TBL] [Abstract][Full Text] [Related]
12. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors.
Langlois RG; Bigbee WL; Kyoizumi S; Nakamura N; Bean MA; Akiyama M; Jensen RH
Science; 1987 Apr; 236(4800):445-8. PubMed ID: 3563520
[TBL] [Abstract][Full Text] [Related]
13. Biological dosimetry of radiation workers at the Sellafield nuclear facility.
Tucker JD; Tawn EJ; Holdsworth D; Morris S; Langlois R; Ramsey MJ; Kato P; Boice JD; Tarone RE; Jensen RH
Radiat Res; 1997 Sep; 148(3):216-26. PubMed ID: 9291352
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
[TBL] [Abstract][Full Text] [Related]
15. Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation.
Kodama Y; Pawel D; Nakamura N; Preston D; Honda T; Itoh M; Nakano M; Ohtaki K; Funamoto S; Awa AA
Radiat Res; 2001 Oct; 156(4):337-46. PubMed ID: 11554845
[TBL] [Abstract][Full Text] [Related]
16. Did atomic bomb radiation influence the incidence of retinoblastoma in Nagasaki and Hiroshima?
Amemiya T; Takano J; Choshi K
Ophthalmic Paediatr Genet; 1993 Jun; 14(2):75-9. PubMed ID: 8233356
[TBL] [Abstract][Full Text] [Related]
17. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
[TBL] [Abstract][Full Text] [Related]
19. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the degree of curvature in the cancer incidence dose-response in Japanese atomic bomb survivors with that in chromosome aberrations measured in vitro.
Little MP
Int J Radiat Biol; 2000 Oct; 76(10):1365-75. PubMed ID: 11057745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
